FDAPhase
7-29-11 abstracts (only 3!)
Submitted by michael on Fri, 2011-07-29 23:26You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
19: Low-dose diethylstilbestrol for the treatment of advanced prostate cancer.
Urol Oncol. 2011 Jul 25; [Epub ahead of print]
- Read more
- 2714 reads
Interesting PubMed items 8/4/10
Submitted by michael on Wed, 2010-08-04 23:48An occasional ongoing series of my results as I train my classifier. I have over 400 abstracts in the training set, and I still get dreck sometimes. Hope this is of some assistance to someone....
1: PMID 20677480 Endometrial ablation with paracervical block.
2: PMID J Reprod Med. 2009 Oct;54(10):639-44. Breast mass in a patient with ovarian cancer: a case report.
- Read more
- 1839 reads
Novel Hsp90 Inhibitor to Begin Phase 1 Study in Cancer Patients
Submitted by Anonymous on Wed, 2009-04-08 17:22- Adrian Hobden
- apoptosis
- Azixa
- breast cancer
- Cancer
- cancer
- Cancer Treatment
- cancers
- chemical
- Clinical trial
- colon cancer
- Company Affiliates
- Company Ticker
- disease
- drug development
- Drug discovery
- FDA
- FDAPhase
- finance
- gastric cancer
- gastric cancers
- glioblastoma
- Health
- Health
- healthcare
- HIV
- Hsp90
- Hsp90
- Labor
- Labor
- lung cancer
- manufacturing
- Medicine
- melanoma
- metastasis
- MPC-3100
- MPC-4326
- multiple myeloma
- myeloid leukemia
- Myriad Genetics Inc.
- Myriad Pharmaceutical
- Myriad Pharmaceuticals Inc.
- Myriad Pharmaceuticals’ Development Programs Myriad Pharmaceuticals
- Occupational safety and health
- Pathology
- pharmacokinetics
- President
- Private
- Prostate cancer
- prostate cancer
- Salt Lake City
- Securities and Exchange Commission
- Social Issues
- Social Issues
- Technology
- Technology
- TopoTarget
- treatment of a wide range of cancers
- treatment of cancer
- treatment of HIV
- treatment of primary glioblastoma and melanoma
- tumor
- United States
- www.myriad.com
Salt Lake City April 8 2009 -- Myriad Pharmaceuticals Inc. announced today that the FDA has approved an Investigational New Drug (IND) application to begin a Phase 1 clinical study with its Hsp90 inhibitor MPC-3100 for the treatment of cancer. The clinical development plan for MPC-3100 is designed to expedite the drug candidate through the clinical development path. The Phase 1 trial will assess the safety and pharmacokinetics profile of MPC-3100.
- Read more
- 1949 reads
Gleevec gets post-op prevention indication for GIST
Submitted by Anonymous on Thu, 2008-12-25 11:07- American College of Surgeons Oncology Group
- Anatomical pathology
- Cancer
- Chronic myelogenous leukemia
- Disaster
- Disaster
- Duke Clinical Research Institute
- European Union
- FDAPhase
- Gastrointestinal cancer
- Gastrointestinal stromal tumor
- Gleevec
- Imatinib
- Japan
- Medicine
- National Cancer Institute
- Novartis
- Novartis
- Oncology
- Philadelphia
- Philadelphia chromosome
- President and CEO
- Sarcoma
- Surgeons Oncology Group
- the American College
- treatment of this life-threatening cancer
- Tyrosine kinase inhibitors
- U.S. Food and Drug Administration
- Z9001
Gastrointestinal stromal tumor (GIST) is a critical cancer of the gastrointestinal tract. It is also known as soft tissue sarcomas. The prevalence of GIST is likely to be 4 500 - 6 000 new cases per year in the US. Surgery is the normal treatment of local GIST. GIST tumors more often recurs in as many as one of two patients after its initial removal. Repeated GISTs are frequently more persistent than primary tumors with relapses related with lower survival rates. Gleevec is the lone treatment recognized to delay the recurrence of this aggressive cancer.
- Read more
- 1958 reads
First gout drug in forty years nears approval
Submitted by Anonymous on Mon, 2008-12-01 08:12Gout is a painful condition that occurs when the bodily waste product of uric acid precipitates as needle-like crystals in the joints and/or soft tissues. In the joints these crystals cause inflammatory arthritis which results in sporadic swelling redness heat and pain in the joints. In many people gout mainly affects the joints of the big toe a condition known as podagra. Many other joints and areas around the joints like the insteps ankles heels knees wrists fingers and elbows can also be affected. Uric acid crystals can also form in the kidneys and results in kidney stones.
- Read more
- 1113 reads